“There was not a lot of transparency,” he said. It was all Theranos, all the time for Elizabeth.” He said he met with her four to five times a year, and in those meetings, he didn’t hear any bad news about the company. Very sincere about what she was trying to do. “She was very passionate about the project. Lucas’ uncle, investor Donald Lucas, was chairman of Theranos’ board until 2012. The first was Chris Lucas, whose venture capital firm Black Diamond invested over $2 million in two investments in 2006 and another $5.4 million in December 2013. The witnesses who did take the stand yesterday, though, appeared to bolster the government’s case. Silicon Valleys go-go venture capital system has gone on trial in a packed, fifth-floor courtroom in downtown San Jose. to Theranos regarding laboratory blood test results.” Without that, Holmes still faces nine counts of wire fraud and two counts of conspiracy to commit wire fraud. Judge Davila didn’t excuse the mistake.Īs a result of the error, the prosecution now won’t have testimony to support one of the charges of wire fraud, which cited a “telephone call from patient B.B. Platelets are important to the clotting process, and while both tests may provide insight into a clotting-related condition, there is a difference between the two. “It sounds like the government may have been confused about which tests it was charging,” Holmes’ attorney Katherine Trefz said. Bostic said the patient was likely to testify about whether he had symptoms related to an elevated platelet count. On the other hand, Holmes shied away from venture capital firms who would. had taken a test for blood clotting, which was included in court documents. Theranos investors testified at Elizabeth Holmes trial that they lost. The company raised 945 million from famous venture capitalists including Tim Draper, Donald Lucas and Dixon Doll wealthy heirs to the founders of Amway, Walmart and Cox Communications and. Assistant US attorney John Bostic admitted that prosecutors were “confused.” They thought that B.B. The judge agreed, saying that because the test wasn’t included in court documents, Holmes’ attorneys wouldn’t have time to prepare an adequate defense. former Theranos CEO Elizabeth Holmes was found. Holmes’ attorneys had filed a motion last week to block his testimony, saying that the test in question, a complete blood count, wasn’t included in a list of 25 tests that the government claimed Theranos couldn’t consistently or accurately produce results for. In a decision that may serve as yet another a warning to other tech startups that have raked in millions of dollars in venture capital based. The onetime Theranos patient identified in court documents as “B.B.” was supposed to testify about “suspicious” test results he received in 2015. Judge Edward Davila ruled that a witness that the prosecution had flown in from out of state wouldn’t be able to take the stand. The prosecution had an up-and-down day in court yesterday during the criminal trial of Elizabeth Holmes, the founder of failed medical diagnostic startup Theranos. David Paul Morris/Bloomberg reader comments 138 with
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |